G. Kelly Martin - Feb 21, 2022 Form 4 Insider Report for Radius Health, Inc. (RDUS)

Role: CEO and President, Director
Signature: /s/ G. Kelly Martin
Stock symbol: RDUS
Transactions as of: Feb 21, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/23/2022, 04:08 PM
Next filing: Aug 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RDUS	Common Stock	Award	$0	+960K		$0.00	960K	Feb 21, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units awarded under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock (Common Stock). 240,000 of the restricted stock units will become earned in the event that during the period beginning on February 21, 2022 and ending on February 21, 2025 (Performance Period) the 30-day trading day average price of the Common Stock is equal to at least $10 per share, 240,000 of the restricted stock units will become earned if during the Performance Period, the 30-day trading day average price of the Common Stock is equal to at least $15 per share, and 480,000 of the restricted stock units will become earned if during the Performance Period, the 30-day trading day average price of the Common Stock is equal to at least $20 per share.
F2	A portion of such restricted stock units will vest upon the Common Stock price hurdle being met and a portion of such restricted stock units will vest at the end of the Performance Period, generally subject to continued service with RDUS through such dates and subject, in the case of those restricted stock units that vest at the end of the Performance Period, to a minimum 30-day trading day average price of the Common Stock as of the end of the Performance Period of $10 per share.

Content

Represents restricted stock units awarded under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock (Common Stock). 240,000 of the restricted stock units will become earned in the event that during the period beginning on February 21, 2022 and ending on February 21, 2025 (Performance Period) the 30-day trading day average price of the Common Stock is equal to at least $10 per share, 240,000 of the restricted stock units will become earned if during the Performance Period, the 30-day trading day average price of the Common Stock is equal to at least $15 per share, and 480,000 of the restricted stock units will become earned if during the Performance Period, the 30-day trading day average price of the Common Stock is equal to at least $20 per share.

A portion of such restricted stock units will vest upon the Common Stock price hurdle being met and a portion of such restricted stock units will vest at the end of the Performance Period, generally subject to continued service with RDUS through such dates and subject, in the case of those restricted stock units that vest at the end of the Performance Period, to a minimum 30-day trading day average price of the Common Stock as of the end of the Performance Period of $10 per share.